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Parkinson’s disease is the most diffused neurodegenerative disease involving
movements. The protein alpha-synuclein must be linked to the disease by two
lines of evidence: first, amyloid-like fibrils of the protein are found in patients’
brains; second, three missense mutations in the gene of alpha-synuclein and
the gene triplication itself cause autosomal dominant early onset forms of the dis-
ease. Recent outcomes underlined that alpha-synuclein oligomers are toxic for
cells and may be responsible for cell death in Parkinson’s disease. The precise
role of oligomers in the etiopathogenesis of the disease is still under debate. In
this study we use single molecule FRET to catch differences in the overall struc-
ture of oligomers generated from wild-type and A53T, A30P and E46Kmutants.
FRET efficiencies distributions reported by the mutants oligomers sets are
different compared to the wild-type protein. This opens the possibility that olig-
omers with different structures may have different targets or may be differently
processed by cells. Results obtainedwith this techniquemay contribute to the un-
derstanding of early onset Parkinson’s disease generated by the mutants.
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Sequence-specific information on the fibril-fold of a-synuclein (aS), which is
required for understanding fibrilization and the role of aS in Parkinson’s disease,
is still scarce. Double Electron Electron Resonance (DEER) on doubly spin-
labelled aS potentially gives access to distances in the nm-range. Fibrillizing the
labelled protein in a background of wild-type aS, intramolecular distances are
emphasized, but intermolecular distances cannot be suppressed completely, lead-
ing tosuperposition traces that are difficult todisentangle.Nevertheless, long-range
distance constraints are beginning to emerge. We compare distances between res-
idue pairs 56-69, 56-90 and 69-901 to recent results of Pornsuwan et al.2
Are these constraints consistent with the simplest model, in which the protein is
in a plane perpendicular to the fibril axis, with all b-sheets parallel? If not, it
could be that a more complicated fold pertains, such as a situation where not
all the b-sheets are parallel to each other or that the protein extends over
different planes along the fibril axis. Also, different fibril forms, e.g. different
morphologies, could be the cause. We will discuss these possibilities.
References
1 Hashemi-Shabestari et al. Biophys.J. 102, Supplement 1, Page 454a.
2Kayagina et al. Biophys. J. (2011) 101, L1-L3.
Pornsuwan et al. Angewandte Chem. (2013) DOI: 10.1002/anie.201304747.
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Small oligomers of Ab are suspected to initiate Alzheimer’s disease (AD).
However, their low concentration and transient nature under physiological con-
ditions have thwarted efforts to determine their structure. Using time resolved
FRET spectroscopy, we have recently shown that the monomers are relatively
unstructured, and the aggregation process starts with the two terminals of the
peptide coming closer in the small oligomers (n-mers with n<10)1. Here we
develop a method which combines rapid fluorescence techniques with slower
two-dimensional solid state NMR, and probe nascent Ab40 oligomers which
demonstrate an enhanced ability to attach to cell membranes compared to the
monomers2. We find that the conformation of the two hydrophobic arms (res-
idues 10-22 and 29-40) have already reached the conformation observed in the
fibrils. However, the turn region (residues 23 to 28) and the N-terminal tail (res-
idues 1-9) are strikingly different. Notably, majority of the Ab mutants linked
to familial AD map to these two regions, and toxicity modulators such as Znþþ
affect the same region3. Our results provide specific structural targets for ther-
apeutic strategies designed to modulate Ab oligomers.Reference:
1. S. Nag, B. Sarkar, M. Chandrakesan, R. Abhyankar, D. Bhowmik, M. Kom-
brabail, S. Dandekar, E. Lerner, E. Haas and S. Maiti, Physical chemistry
chemical physics: PCCP, 2013.
2. B. Sarkar, A.K.Das and S.Maiti, Front. Physiol. 2013, 4(84), 1-11.
3. V.S.Mithu, B. Sarkar, D Bhowmik, M. Chandrakesan, S. Maiti and
P.K.Madhu, Biophysics. J. 2011, 101, 2825.
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Amyloid b (Ab) monomers represent the base state in the pathways of aggre-
gation that result in the fibrils and oligomers involved in Alzheimer’s disease
(AD). The structural properties of these intrinsically disordered peptides remain
unclear despite extensive efforts to resolve these through experiment and
computation. Comparison of all-atom, explicitly solvated simulations of wild
type Ab monomers simulated with different force fields (OPLS-AA/L and
AMBER99sb-ILDN) and water models (TIP3P and TIP4P-Ew) nevertheless
demonstrate a convergence in structural properties and good agreement with
experimental NMR observables. In Ab42, antiparallel b-hairpin structure be-
tween L17-A21, A30-L34, and V40-I41 is prevalent in these ensembles. While
residues 21-30 forms an interceding region in both simulations that rarely inter-
acts with the majority of the protein, the structure of this region and the elec-
trostatic interactions that characterize it are notably different between the
two. To further explore these differences, NMR experiments and simulations
using both combinations have been conducted for familial AD (FAD) muta-
tions that perturb residues 22 and 23, observed in our wild type Ab simulation
data to be pivotal in determining the structure of this central region. The char-
acterizations made here suggest simulation conditions that best reproduce the
experimental data and help clarify how FADmutations drive Ab to aberrant ag-
gregation pathways that result in disease phenotypes.
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Although the natural tendency of proteins is to acquire soluble native-like func-
tional states, they are able to undertake alternative pathways, such as
self-association into ordered insoluble amyloid fibrils. The latter are protein ag-
gregates that share common cross-b sheet structures and give rise to various
incurable disorders, such as Alzheimer’s and Parkinson’s diseases. The
abnormal self-assembly of amyloid beta (Ab), an intrinsically disordered pep-
tide, into neurotoxic oligomers and fibrils is strongly associated with Alzheim-
er’s disease, thus prompting a comprehensive search for small compounds
capable of inhibiting its aggregation. Although many compounds have been re-
ported with this effect, the mechanisms by which they act are still largely un-
clear. In the present study, we use Small-Angle X-Ray Scattering (SAXS) as a
high-throughput tool to screen an in-house fragment-based library in an attempt
to identify new potential inhibitors targeting Ab aggregation. We follow the
fibrillation process of Ab in solution over time in order to resolve major co-
exisiting species and monitor by SAXS the effect of small compounds on these
species. This approach is expected to provide molecular insights into Ab self-
assembly mechanism and lead effectively to much needed new treatment
options.
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Alzheimer’s Amyloid-b (Ab) peptide changes its conformation as it aggregates
(1) and acquires toxicity, ultimately causing Alzheimer’s disease. Since it is diffi-
cult to decouple conformational changes from aggregation, any cause-effect rela-
tionship between them remains poorly explored. Here we attach Alzheimer’s
Amyloid-b40 monomers to silver nanoparticles, preventing their aggregation,
and study their conformation under aggregation-favoring conditions using
SERS. Surprisingly, the a-helical character of the peptide remains unchanged
270a Monday, February 17, 2014between pH 10.5 and 5.5, while the solubility changes>100x. We infer that am-
yloid aggregation can start without significant conformational changes.
A significant part of the aggregation / organization of this extra cellular peptide
probably takes place in the in the lipid membrane. The affinity of the monomers
and oligomers for the lipid membrane, and the conformation that they adopt
there, remain open questions. We have recently found that Ab exhibits a strong
enhancement in its membrane-affinity as it transforms from monomers to olig-
omers (2). Using Fluorescence Correlation Spectroscopy, we have now estab-
lished a rapid and quantitative assay for this affinity. Further, using SERS of
lipid bilayer coated gold nano-particles, we are currently investigating the
conformation of Ab in lipid environments.
1. Nag, S., Sarkar, B., Bandyopadhyay, A., Sahoo, B., Sreenivasan, V. K.,
Kombrabail, M., Muralidharan, C., and Maiti, S. (2011) Nature of the
amyloid-beta monomer and the monomer-oligomer equilibrium. J Biol Chem
286, 13827-13833.
2. Sarkar, B., Das, A. K., and Maiti, S. (2013) Thermodynamically stable
amyloid-beta monomers have much lower membrane affinity than the small
oligomers. Front Physiol 4, 84.
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Protective effects of Transthyretin (TTR) ameliorate Alzheimer’s pathology in
mice models. This suggests a possible route for cellular defense mechanism
against toxic effects of protein misfolding and aggregation. This view is further
supported by the results from in vitro experiments showing direct interactions
between TTR and amyloid-b (Ab) peptides. However, the molecular mecha-
nism of the TTR-Ab interactions is currently unknown primarily due to hetero-
geneities associated with self-association of both TTR and Ab. Here we
investigate the mechanism of TTR-Ab interactions by examining the effects
of WT-human, a monomeric mutant and murine TTR on the kinetics of aggre-
gation of both Ab1-40 and Ab1-42. The three of forms of TTR differ in terms
of stability as tetramers or monomers, e.g., the WT-human and murine TTR are
primarily tetramers but the tetramers of murine TTR are more stable. To
monitor the aggregation of Ab but not of TTR we use a recently developed ag-
gregation assay based on the fluorescence quenching of tetramethyl rhodamine
(TMR)-labeled Ab. Our data indicate that all three TTR variants delay aggre-
gation of both Ab1-40 and Ab1-42. However, the effects are strongest for the
monomeric mutant and weakest for the murine TTR. Kinetic measurements of
fluorescence resonance energy transfer between native tryptophan residues of
TTR and the EDANS-labeled Ab indicate that binding of TTR is dependent
on the aggregation status of Ab with maximal binding occurring to larger ag-
gregates of Ab. Additionally, the modulatory effects of TTR are stronger on
Ab1-42 than on Ab1-40 consistent with the known higher oligomerization pro-
pensity for Ab1-42. Taken together our results indicate that the tetramers of
WT-human TTR dissociates to monomers to bind to the aggregation interme-
diates of Ab to subsequently slow down the growth of these intermediates.
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Epidemiologically, type-2 diabetes (T2D) doubles the risk for dementia linked
to cerebrovascular disease and/or Alzheimer’s disease (AD). We have recently
found that, in addition to plaques laden with Ab, the brain of demented T2D
patients also contains large deposits of amylin, a protein that makes up the
pancreatic amyloid in T2D. Deposition of amylin (or islet amyloid polypeptide;
IAPP) is promoted by hyperamylinemia, a key component of the metabolic
syndrome. In the brain, amylin was identified in the blood vessel wall, perivas-
cular space and tissue parenchyma. Moreover, we found amylin forming the
core protein deposit of some amyloid plaques or co-localized with Ab in com-
bined plaques suggesting an amylin-Ab pathology. Intriguingly, amylin depo-
sition was also detected in brain specimens from patients with AD without
clinically apparent diabetes. Amylin pathology in AD brain was similar to
that in brain samples from the T2D patients group, including buildup on blood
vessel walls and parenchyma. In contrast, brain specimens from age-matched
healthy humans show only sporadic amylin deposits in blood vessels and brainparenchyma. Cerebral deposition of amylin in non-diabetic AD patients may be
due to insulin resistance, which is common in aging.
To test the impact of hyperamylinemia on brain function, we use a rat model of
T2D expressing human amylin in the pancreas (the HIP rat). We found that the
infiltration of oligomerized amylin in cortical arteries induces lipid peroxida-
tion and triggers an inflammatory response. As a result, HIP rats display
changes in spontaneous activity and coordination. In contrast, rats matched
for weight, glucose and age, but expressing only the non-amyloidogenic rat
amylin, show no amylin accumulation and no behavioral changes.
In conclusion, hyperamylinemia promotes amylin deposition in the brain contrib-
uting to the development of cerebrovascular injury and neurological deficit.
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Tau is a non-motor microtubule-associated protein which functions to maintain
microtubule stability, primarily in the axons of neurons. The loss of this normal
function, along with the aggregation and deposition of tau as neurofibrillary
tangles, contributes to tau pathology in various neurodegenerative disorders,
including Alzheimer’s disease. Moreover, tau is reported to be an important
regulator to motor proteins in microtubule-based transport. While interactions
between tau and microtubules are of great interest, a detailed structural charac-
terization is lacking. Tau is intrinsically disordered, lacking stable secondary
and tertiary structure in solution, which makes it challenging to investigate
its structural features by conventional techniques. Here we use single molecule
Foster Resonance Energy Transfer (FRET) to probe the structure of tau bound
to microtubules in order to establish a structural framework for the mechanism
by which tau stabilizes microtubules. These measurements will not only pro-
vide insight into functional aspects of tau but also into the loss-of-function rele-
vant to disease.
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Biological processes offer several intriguing examples of directed self-
assembly into higher order structures that influence human health and well-
being. The aggregation of microtubule associating protein Tau, an intrinsically
disordered soluble protein that forms neurofibrillar tangles in cells in Alzheim-
er’s disease may be directed by the presence of hydrophobic templates. Using
various lipid monolayers and lipid-free surfaces we monitor the adsorption and
aggregation kinetics of Tau proteins to these model membranes. Monitoring the
surface tension change shows a two-step adsorption process followed by these
proteins. A novel microrheology and quartz crystal microbalance study shows
that the first step is dominated by the N-terminus of peptide, while the second
step is possibly due to an intermediate hair-pin structure. Our microrheology
data also show that the viscoelastic properties of these proteins is dominated
by the proteins propensity to aggregate.
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Tau is a microtubule binding protein that forms pathological aggregates in the
brain in Alzheimer’s disease and other tauopathies. Disease etiology is thought
to arise from loss of native interactions between tau and microtubules, as well
as from gain of toxicity tied to tau aggregation, although neither mechanism is
well-understood. We have investigated the link between function and disease
using disease-associated and designed disease-motivated mutants of tau. We
used fluorescence correlation spectroscopy (FCS) to measure tau binding to
free tubulin. We find that while the mutants bind stabilized microtubules
with comparable affinities, they demonstrate an increased affinity for tubulin
dimers. Morover, the mutant forms of tau are impaired in their ability to pro-
mote microtubule assembly. Using single
molecule FRET, we measure conforma-
tional changes in tau upon binding to
tubulin that provide a structural frame-
work for the observed altered affinity
and function. We propose a model that de-
scribes tau binding to tubulin dimers and a
